News
WAT
304.18
-3.04%
-9.54
Oversold Conditions For Waters (WAT)
NASDAQ · 1d ago
Weekly Report: what happened at WAT last week (0408-0412)?
Weekly Report · 3d ago
Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March
Short percentage in S&P 500’s healthcare companies surged in the end of March from February. Life science tools and services was the most shorted industry in the healthcare sector for March end. Average short interest in s&p 500 health stocks rises to 1.57% in March. Moderna among mostShorted companies in March with 6.42% of float.
Seeking Alpha · 5d ago
Waters Corporation Schedules First Quarter 2024 Earnings Conference Call
Waters Corporation will hold its Q1 2024 financial results conference call live on Tuesday, May 7th, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters Investor Relations website. Waters Corporation is a global leader in analytical instruments and software.
PR Newswire · 6d ago
Waters Corporation Unveils Alliance iS Bio HPLC System To Help Biopharma QC Labs Increase Efficiency And Reduce Errors
New Alliance™ iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errors. MaxPeak™ High Performance Surface (HPS) Technology minimizes unwanted analyte interactions.
Benzinga · 04/09 07:43
Waters Launches Alliance iS Bio HPLC System to Help Biopharma QC Labs Increase Efficiency and Reduce Errors
Alliance iS Bio High Performance Liquid Chromatography (HPLC) System helps biopharmaceutical QC laboratories boost efficiency and eliminate up to 40% of common errors. New system features MaxPeak™ High Performance Surface (HPS) Technology to minimize unwanted analyte interactions. The new HPLC system combines advanced bio-separation technology and built-in instrument intelligence features.
PR Newswire · 04/09 06:00
BUZZ-U.S. STOCKS ON THE MOVE-Ocugen, Model N, Fastly
Futures tracking Wall Street's main indexes were largely muted on Monday. Treasury yields rose on rising bets that the U.S. Federal Reserve could delay interest-rate cuts this year. Dow e-minis were up 0.13% in early trading. Ocugen up 9.8% on FDA approval of gene therapy for Parkinson's disease.
Reuters · 04/08 13:50
Weekly Report: what happened at WAT last week (0401-0405)?
Weekly Report · 04/08 09:05
Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?
Waters Corporation (NYSE:WAT) saw a double-digit share price rise of over 10% in the past few months. The company's stock is trading around its fair value. Waters is expected to grow its earnings over the next few years by 21%. The company is inching closer to its yearly highs. Could the stock still be trading at a relatively cheap price? We look at Waters's outlook and valuation to see if the opportunity still exists.
Simply Wall St · 04/07 13:13
Validea Detailed Fundamental Analysis - WAT
NASDAQ · 04/05 18:06
Analysts Offer Insights on Healthcare Companies: Waters (WAT) and UnitedHealth (UNH)
TipRanks · 04/05 04:20
Navigating 4 Analyst Ratings For Waters
Analysts have recently evaluated Waters and provided 12-month price targets. The average price target for Waters is $311.25. Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. The company faces challenges managing its debt levels. Waters has an average of 4 analysts who have evaluated the company.
Benzinga · 04/04 21:00
Waters Corp Price Target Raised to $340.00/Share From $320.00 by Evercore ISI Group
Dow Jones · 04/04 17:15
Waters Corp Is Maintained at In-Line by Evercore ISI Group
Dow Jones · 04/04 17:15
Evercore ISI Group Maintains In-Line on Waters, Raises Price Target to $340
Benzinga · 04/04 17:05
The most shorted S&P 500 stocks as a percentage of float - BofA
The most shorted S&P 500 stocks as a percentage of float - BofA Securities. An estimated 85% of total short interest in stocks is from hedge funds. Energy is the mostShorted sector, with the largest increase in short interest over the last three months.
Seeking Alpha · 04/01 14:17
Weekly Report: what happened at WAT last week (0325-0329)?
Weekly Report · 04/01 09:05
Weekly Report: what happened at WAT last week (0318-0322)?
Weekly Report · 03/25 09:05
LivaNova (LIVN) Soars 12.5%: Is Further Upside Left in the Stock?
NASDAQ · 03/21 08:46
We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt
Waters Corporation (NYSE:WAT) has US$2.37b of debt at the end of December 2023. The company has a healthy balance sheet, with a moderate use of debt. Debt is an important factor in assessing a company's ability to manage its debt. Waters's debt is less than half its earnings before interest and tax. This suggests the company is in a good position to pay down debt. But should shareholders be worried about its debt? We look at Waters's free cash flow to assess its debt levels.
Simply Wall St · 03/19 10:03
More
Webull provides a variety of real-time WAT stock news. You can receive the latest news about Waters through multiple platforms. This information may help you make smarter investment decisions.
About WAT
Waters Corporation offers analytical instruments and software across chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, food, and environmental sciences. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Its segments include Waters and TA. The Waters segment is primarily in the business of designing, manufacturing, selling and servicing liquid chromatography (LC) and MS instrument systems, columns and other precision chemistry consumables that can be integrated and used along with other analytical instruments. The TA segment is primarily in the business of designing, manufacturing, selling and servicing thermal analysis, rheometry and calorimetry instruments.